BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong Y, Yan W, Zhang SL, Zhang MZ, Zhou YP, Ling HH, Ning M, Zhao Y, Huang A, Zhang P. Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy. Oncotarget 2017;8:114041-9. [PMID: 29371967 DOI: 10.18632/oncotarget.23110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Gao L, Xiong DD, He RQ, Yang X, Lai ZF, Liu LM, Huang ZG, Wu HY, Yang LH, Ma J, Li SH, Lin P, Yang H, Luo DZ, Dang YW, Chen G. MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays. Onco Targets Ther 2019;12:9827-48. [PMID: 31819482 DOI: 10.2147/OTT.S227541] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
2 Sun Q, Tripathi V, Yoon JH, Singh DK, Hao Q, Min KW, Davila S, Zealy RW, Li XL, Polycarpou-Schwarz M, Lehrmann E, Zhang Y, Becker KG, Freier SM, Zhu Y, Diederichs S, Prasanth SG, Lal A, Gorospe M, Prasanth KV. MIR100 host gene-encoded lncRNAs regulate cell cycle by modulating the interaction between HuR and its target mRNAs. Nucleic Acids Res 2018;46:10405-16. [PMID: 30102375 DOI: 10.1093/nar/gky696] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
3 Liu J, Wei Y, Wang T, Zhang Z, Huang H, Wang C, Li H, Jia Q, Wu H, Zou T. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysis. Int J Biol Markers 2020;35:3-11. [PMID: 33208027 DOI: 10.1177/1724600820965579] [Reference Citation Analysis]
4 Lei T, Zhu X, Zhu K, Jia F, Li S. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway. Cancer Biol Ther 2019;20:1007-16. [PMID: 30929558 DOI: 10.1080/15384047.2019.1595276] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
5 Huang GD, Liao P, Huang YH, Wu YL, Wu Y, Chen SQ, Xiong J. MIR22HG Regulates the Proliferation, Epithelial-Mesenchymal Transition, and Apoptosis in Colorectal Carcinoma. Cancer Biother Radiopharm 2021. [PMID: 33493419 DOI: 10.1089/cbr.2019.3509] [Reference Citation Analysis]
6 Li H, Wang Y. Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling. Med Sci Monit 2019;25:656-65. [PMID: 30670679 DOI: 10.12659/MSM.912813] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
7 Yuan D, Chen Y, Li X, Li J, Zhao Y, Shen J, Du F, Kaboli PJ, Li M, Wu X, Ji H, Cho CH, Wen Q, Li W, Xiao Z, Chen B. Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis. Int J Biol Sci 2021;17:220-35. [PMID: 33390845 DOI: 10.7150/ijbs.50730] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zhang W, Shi C, Xu Q, Chen X, Zhu H, Zheng B. Long non-coding RNA MIR22HG suppresses cell proliferation and promotes apoptosis in prostate cancer cells by sponging microRNA-9-3p. Bioengineered 2022;13:13108-17. [PMID: 35611601 DOI: 10.1080/21655979.2022.2079244] [Reference Citation Analysis]
9 Hu X, Tan Z, Yang Y, Yang P. Long non‐coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β‐catenin signaling pathway. J Gene Med 2019;21:e3085. [DOI: 10.1002/jgm.3085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wu Y, Zhou Y, Huan L, Xu L, Shen M, Huang S, Liang L. LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells. Cancer Sci 2019;110:973-84. [PMID: 30680848 DOI: 10.1111/cas.13950] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 9.7] [Reference Citation Analysis]
11 Wu Y, Wang PS, Wang BG, Xu L, Fang WX, Che XF, Qu XJ, Liu YP, Li Z. Genomewide identification of a novel six-LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma. Cancer Med. 2018;7:6219-6233. [PMID: 30378276 DOI: 10.1002/cam4.1854] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
12 Cui Z, An X, Li J, Liu Q, Liu W. LncRNA MIR22HG negatively regulates miR-141-3p to enhance DAPK1 expression and inhibits endometrial carcinoma cells proliferation. Biomed Pharmacother 2018;104:223-8. [PMID: 29775889 DOI: 10.1016/j.biopha.2018.05.046] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
13 Wen C, Yang S, Zheng S, Feng X, Chen J, Yang F. Analysis of long non-coding RNA profiled following MC-LR-induced hepatotoxicity using high-throughput sequencing. J Toxicol Environ Health A 2018;81:1165-72. [PMID: 30430930 DOI: 10.1080/15287394.2018.1532717] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
14 Khajehdehi M, Khalaj-Kondori M, Ghasemi T, Jahanghiri B, Damaghi M. Long Noncoding RNAs in Gastrointestinal Cancer: Tumor Suppression Versus Tumor Promotion. Dig Dis Sci 2021;66:381-97. [PMID: 32185664 DOI: 10.1007/s10620-020-06200-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Shi W, Hu D, Lin S, Zhuo R. Five-mRNA Signature for the Prognosis of Breast Cancer Based on the ceRNA Network. Biomed Res Int 2020;2020:9081852. [PMID: 32964046 DOI: 10.1155/2020/9081852] [Reference Citation Analysis]